So, Tepotinib is a drug that targets the MET inhibitor in NSCLC, mainly for patients with a specific kind of mutation called MET exon 14 skipping. It works by stopping the MET signaling process. You can get Tepotinib as a 225 mg pill with a coating.
The dose they usually suggest is 450 mg, and you take it once a day, preferably with some food. Each pack comes with 30 of those pills.
